View all blogs:
Liposomal generics in Asia: Supporting scalable drug delivery through GMP lipid excellence
Pharma
Across Asia, healthcare systems are balancing rising disease burden, expanding access expectations, and increasing cost pressures, making generic medicines central to national healthcare strategies
The Hidden Supply Chain Risk in Vaccines: Why Sustainably Sourced Squalene Matters
Pharma
Ingredient security is no longer a background consideration for vaccine formulators and manufacturers. It is now critical high-quality ingredients are sourced from proven partners, that can provide a...
A 3rd Consecutive Win: Croda Pharma Awarded Pharma Excipients Champion and Sustainability Influencer Award at CPHI China
Pharma
Croda Pharma Secures New Wins in Pharmaceutical Excipients and Sustainability
Croda nominated for Low Carbon Industrial Project of the Year award at the UK Green Business Awards 2026
Pharma
Each year, the UK Green Business Awards offer a unique opportunity to highlight some of the most exciting, inspiring, and innovative companies, projects, and campaigns operating in the UK today, while...
Consumer trends: how consumer expectations are reshaping topical pharmaceuticals
Pharma
The topical pharmaceutical game is changing. Success is no longer shaped by efficacy alone, with consumer’s expectations increasingly redefining the industry.
Croda’s Avanti Research™ expands advanced lipid technologies through collaboration with NovoArc
Pharma
Avanti Polar Lipids, LLC, a wholly owned subsidiary of Croda International Plc, and NovoArc GmbH (NovoArc) are pleased to announce a strategic collaboration to expand global access to advanced lipid...
Partnership to protect biodiversity
Pharma
Discover how Sustainably Sourced Squalene relates to the advice from the IPBES, the Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services (IPBES).
Replacing Triton™ X‑100 Without Compromise: Meet Virodex™
Pharma
If you were at BioProcess International Europe this year, you may have caught a glimpse of us talking about detergent alternatives for viral inactivation. If you weren’t, or if you’ve since heard the...
Bioprocessing spotlight: Meet the Croda Pharma experts heading to BioProcess International Europe
Pharma
As BioProcess International Europe in Vienna approaches this Spring, we’re excited to take part in the conversations around technologies, trends and meet the people translating science into progress.
BioXPro™ high purity amino acids now available
Pharma
Croda successfully launches new Amino Acid range BioXPro™: Croda International Plc (“Croda”) today confirms the successful introduction of its latest portfolio of high purity amino acids, developed to...
Spotlight on Amino Acids with Christian Wells
Pharma
This week we sat down with Christian Wells to discuss all things amino acids
Meeting the demand for sulphate-free oral care
Pharma
Formulators are seeking gentle yet effective surfactants that meet regulatory and consumer expectations. That’s where Adinol™ CT95 comes in...
Spotlight on R&D - Tina Baharlou, Industrial Placement Student
Pharma
This week we caught up with Tina Baharlou, a current Industrial placement student based at our Head Office labs in the UK. Tina has spent the past year immersed in advanced formulation work focused on...
An FAQ session with our lanolin manufacturing experts
Pharma
We sat down with our manufacturing experts to discuss lanolin
The Nitrosamine challenge in pharmaceuticals
Pharma
Since 2018 the risk of nitrosamine impurities in medicinal products has become a critical concern for pharmaceutical manufacturers and regulators alike
Gain insights from our experts...
Pharma
Explore our poster: Optimising lipid nanoparticles (LNPs) processing for siRNA delivery by microfluidics system. The success of mRNA vaccines during the COVID-19 pandemic has accelerated the...
Croda celebrates opening of expanded UK facility, bolstering global Super Refined™ capabilities
Pharma
Croda International Plc (“Croda”), the company that uses smart science to create high-performance ingredients and pharmaceutical excipients that improve lives, celebrated the opening of its newly...
Spotlight on R&D: Geoff Platt
Pharma
This week we spoke to Geoff Platt, Technology Specialist based at our Head Office labs in the UK. Keep reading to learn more about Geoff's background, Protein Delivery challenges, innovations and the...
Croda welcomes Thomas Riermeier as new President of Life Sciences
Pharma
Croda International Plc, the company that uses smart science to create ingredients and technologies that improve lives, today announces that Dr. Thomas Riermeier has been appointed as the new...
From Lab to Patient: Optimising Oncology Formulations with Purified Excipients
Pharma
In 2024, we hosted a live webinar exploring the impact of our Super RefinedTM excipients on various chemotherapeutic formulations. This blog will explore some of the key learnings from the webinar.
Croda’s Avanti Research expands ionizable lipid offering for LNP drug development through Certest collaboration
Pharma
Avanti Polar Lipids, LLC, a wholly owned subsidiary of Croda International Plc, and Certest Biotec S.L. (Certest) are pleased to announce a strategic collaboration to expand the market’s access to...
Protein Leader: Garima Sinha
Pharma
In our latest edition of Protein Leaders, we speak to Garima Sinha. Keep reading to learn more...
Heart Health month
Pharma
February marks Heart Month, this global initiative looks to educate the population on heart disease and what preventative measures can be taken to improve cardiovascular health. In this blog, we...
Plant cholesterol – The future of lipid-based drug delivery
Pharma
While cholesterol is undeniably a key player in lipid formulations, effective across various dosage routes and genetic delivery applications, an important question remains: does the source of...
Lipids Leader: Rasmus Münter, PhD - Lead Research Scientist
Pharma
In our latest edition of Lipid Leaders, we speak to Rasmus Münter, PhD. Rasmus is a lipid-based nanoparticle and vaccine adjuvant expert based in Denmark for Croda Pharma. Keep reading to learn more...
Insights into the veterinary health market
Pharma
The veterinary market in the EMEA region is expected to experience substantial growth in the coming years: 5-8% CAGR. Typically, the veterinary market is categorised into companion animals and...
World Cancer Day 2025
Pharma
In 2022 alone, 9.7 million people worldwide lost their lives to cancer, and the number of new cases is expected to rise to nearly 30 million by 2040. It is a disease that takes so much from so many,...
Croda opens advanced lipids manufacturing facility in Pennsylvania
Pharma
PRESS RELEASE: 15 January 2025: Croda International Plc (“Croda”), the company that uses smart science to create high-performance ingredients and solutions that improve lives, today announces the...
New Research Professor MSO in Vaccine Adjuvants at Statens Serum Institut Copenhagen, Denmark
Pharma
PRESS RELEASE: Croda Pharma is happy to announce that Dennis Christensen, PhD, Head of Global Research and Development for Vaccine Adjuvant Systems, has been appointed as a part-time Research...
Croda Pharma launches a new bioprocessing solution for shear stress in mammalian cell culture
Pharma
Croda Pharma has announced the launch of Super Refined™ Poloxamer 188, an innovative bioprocessing solution developed to meet the increasing demands of biopharmaceutical development.
Announcing Avanti Research - a Croda brand
Pharma
Avanti Polar Lipids, a global leader in lipids, has announced its renewed offering for researchers and its transformation to Avanti Research.
The Oral Hygiene market is evolving
Pharma
Growth in the oral hygiene market is mainly focused around two main categories: toothpastes and mouthwashes. The global oral hygiene market size was valued at USD 31.7 billion in 2020 and is expected...
EXCLUSIVE WHITEPAPER: Next-generation Triton™ X-100 replacements for pharmaceutical bioprocessing
Pharma
Triton™ X-100 (tert-octyl phenyl ethoxylate) is used extensively in the manufacture of biologics, plasma-derived products and cell and gene therapies (CGTs). This non-ionic detergent is used because...
Veterinary vaccines - solutions for an ongoing challenge...
Pharma
Growth in the veterinary pharmaceutical industry continues to be driven by increasing pet ownership globally and the rising demand for veterinary vaccines to prevent the risk of zoonotic diseases in...
QbD Formulation Development
Pharma
Formulation development is a pivotal stage in the life cycle of a therapeutic drug product, it can be the make or break of it. The goal of formulation development is to convert active substance (drug...
Targeted lipid nanoparticles in Nucleic Acid Delivery
Pharma
Targeted lipid nanoparticles (tLNPs) enhance the precision and efficacy of delivering a variety of therapeutic agents including nucleic acids to specific tissues and cell populations, thereby...
Croda joins CGT Catapult consortium to improve AAV formulation
Pharma
The Cell and Gene Therapy Catapult (CGT Catapult) has established a cross-industry consortium to improve the understanding and process optimisation of adeno-associated virus (AAV) formulation.
Synthesis, characterisation and degradation of polysorbates in biopharmaceuticals
Pharma
Polysorbates are essential in biologics delivery, serving as crucial emulsifiers and stabilisers for biopharmaceuticals. They enhance solubility, improve bioavailability, and protect proteins from...
Product Spotlight - Crodamol™ CCC Pharma
Pharma
Crodamol™ CCC Pharma is a mild, non-irritating liquid emollient, ideal for sensitive site applications. The excipient can contribute to many benefits for various topical formulations.
Lipid Leaders: Söhnke Voss
Pharma
In this Lipid Leaders interview, we speak to Söhnke Voss, PhD. Söhnke is a lipids expert with over 25 years’ experience in the pharmaceutical industry. Keep reading to learn more about lipids and the...
Protein Delivery Leaders: Andrew Bright
Pharma
In this Protein Delivery Leaders interview, we speak to Andrew Bright, PhD. Keep reading to learn more about breakthroughs in protein delivery and key challenges faced in biologic formulations.
Croda Pharma wins ‘Best Production/Process Development’ Award at the 17th annual Vaccine Industry Excellence awards
Pharma
Croda Pharma has been awarded winner of a prestigious award for its process development for innovative ingredients, including its production of sustainably sourced Squalene to replace shark-derived...
Croda Foundation announces it has sustainably improved the lives of 22.8 million people – exceeding its 2030 target.
Pharma
Croda Foundation announces it has sustainably improved the lives of 22.8 million people –exceeding its 2030 target.
Product Spotlight - Super Refined PEG 400
Pharma
Super Refined PEG 400 is a highly purified solubiliser is an exemplary excipient in both small molecule and protein formulations containing the most sensitive APIs for treatments of a range of...
Specializing in specific enhancement technologies
Pharma
Croda Pharma specializes in four technologies aimed at improving bioavailability and solubility. Find out more!
Explore our latest downloads!
Pharma
Check out the latest resources from Croda Pharma, available to download today.
Hear directly from our experts...
Pharma
Watch our expert Dr. Kritika Bajaj discuss our product range in more detail and learn how Virodex™ could be the solution to your replacement requirement.
Concerns about Triton™ X-100 have been an ongoing discussion across multiple regulatory authorities around the world
Pharma
Triton™ X-100, a non-ionic surfactant with a hydrophilic polyethylene oxide chain and a hydrophobic aromatic group1, has found widespread use in the biopharmaceutical industry with applications...
“Close the Care Gap” – World Cancer Day 2024
Pharma
We are proud to continue supporting the development of cancer treatments, and on this World Cancer Day, recognise the importance of innovation and science to cure and treat those diagnosed. Together,...
Lets connect...
Register to the mailing list to unlock:
- First access to new products, new data and exclusive literature
- Whitepapers and thought provoking content
- Special offers on conference and exhibition passes when available
- Invitations to invite only Croda Pharma events.
